Table 2. Overall Study Cohort Treatment Outcomes.
Variable | N | % | |
---|---|---|---|
| |||
Primary Treatment | |||
Surgery | 148 | 97.4 | |
Chemo/Rads1 | 4 | 2.6 | |
Surgical Approach | |||
MIS2 | 78 | 52.7 | |
Laparotomy | 62 | 41.9 | |
Groin | 8 | 5.4 | |
Postoperative Course (30 Day) | |||
Intra op complication3 | 14 | 9.5 | |
Postop morbidity4 | 37 | 25.0 | |
ICU Admission | 6 | 4.0 | |
Death | 1 | 0.7 | |
Discharge Location | |||
Home | 143 | 96.6 | |
SNF3 | 4 | 2.7 | |
Acute Rehab6 | 1 | 0.7 | |
Unplanned Post-op Resource Use (30 Day) | |||
Clinic Visit | 9 | 6.1 | |
ER Visit | 18 | 12.1 | |
Readmission | 17 | 11.5 | |
Adjuvant Treatment | |||
Recommended | 94 | 63.5 | |
Not Recommended | 54 | 36.5 | |
Treatment Started | 74 | 78.8% | |
No Treatment started | 20 | 21.2% |
Chemotherapy and/or Radiation
Minimally invasive surgery including laparoscopic, robotic, or hysteroscopic approach
Includes bladder, ureteral, vascular, nerve, and GI injury
Includes VTE/PE, Abscesses, Cardiac event, renal insufficiency, pulmonary events, organ injury, wound infection, wound opening, ileus, blood transfusion, urinary tract infection
Skilled nursing facility or Sub-acute rehabilitation facility
Acute inpatient rehabilitation facility